Brief: Abbott Issues Medical Device Correction For Some Glucose Monitors In U.S.

Abbott Laboratories

24/11/2025 18:29

Nov 24 (Reuters) - Abbott Laboratories ABT.N:

ABBOTT INITIATES MEDICAL DEVICE CORRECTION FOR CERTAIN FREESTYLE LIBRE® 3 AND FREESTYLE LIBRE 3 PLUS SENSORS IN THE U.S.

ABBOTT -NO OTHER LIBRE FAMILY SENSORS, READERS OR APPS ARE IMPACTED

ABBOTT -MEDICAL DEVICE CORRECTION IMPACTS A SUBSET OF FREESTYLE LIBRE 3 AND FREESTYLE LIBRE 3 PLUS SENSORS

ABBOTT: CO CONTINUES TO PRODUCE LIBRE 3 ,LIBRE 3 PLUS SENSORS TO FULFILL REPLACEMENT AND NEW ORDERS,DOES NOT EXPECT SIGNIFICANT SUPPLY DISRUPTIONS

ABBOTT -736 SEVERE ADVERSE EVENTS GLOBALLY (57 IN U.S.) ,7 DEATHS (NONE IN U.S.) LINKED TO CERTAIN FREESTYLE LIBRE 3 AND LIBRE 3 PLUS SENSORS

Further company coverage: ABT.N

 ((Reuters.Briefs@thomsonreuters.com;))